Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
Clinical trial NCT00099918 · COMPLETED
Trial details
- NCT number
- NCT00099918
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-09-01
- Enrollment
- 717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.